Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGolden Pros Regulatory News (GPM)

Share Price Information for Golden Pros (GPM)

Share Price is delayed by 15 minutes
Get Live Data
113.00    -0.50 (-0.44%)
Bid:
112.00
Ask:
114.00
Spread: 2.00 (1.786%)
Market Cap: £111.66m
GPM Live PriceLast checked at - London Stock Exchange

Intraday Golden Pros Share Chart

Net Asset Value(s)

9 Dec 2025 13:21

RNS Number : 8657K
Golden Prospect Precious Metals Ltd
09 December 2025
 

 

 

 

 

Net Asset Value

Golden Prospect Precious Metals Limited (LSE: GPM) announces that as at the close of business on 08 December 2025 its unaudited net asset value ("NAV") per ordinary share ("Share") was as follows:

Date of announcement

09 December 2025

Date of NAV

08 December 2025

NAV per share - undiluted, bid basis

101.69 pence per share

NAV per share - diluted*, bid basis

101.69 pence per share

No of shares in issue for NAV Calculation Purposes (9 December)

107,834,428

Subscription Exercise Price 2026

104.63 pence per share

Next Subscription Date

1 December 2026

 

*Notes relating to the NAV dilution

The dilution is in relation to the effect of the Company's embedded annual Subscription Right. Shareholders should note that the dilution refers to the NAV per share dilution, not to the dilution of Shareholders' holdings in the Company. All Shareholders have the right to take up their subscription rights on 1 December in each year (the "Record Date") and those who do take them up in full don't have their percentage holding in the Company diluted. For those investors who don't take up their subscription rights, the Company endeavours to place in the market the shares that they were entitled to subscribe for, and then return the net sale proceeds to those investors as a way to deliver to them as much as possible of the value of their subscription rights, therefore reducing the dilution effect of not subscribing.

The net asset values as above take account of the issue of 14,585,929 new Ordinary shares arising from the 2025 Subscription Rights exercise as announced on 2 and 3 December2025. These shares have been allotted and will be issued to shareholders on 9 December 2025.

The calculation for the fully diluted NAV per share assumes that the maximum number of shares the Company can issue is 21,566,885 based on the subscription exercise price of 104.63p on 30 November 2026. Please note that the maximum shares that can be issued and the NAV dilution are only current estimates. Any further amendments to the dilution calculation will be communicated in subsequent NAV announcements.

 

About the annual Subscription Right

Shareholders have the right to subscribe for one new Ordinary Share for every five Ordinary Shares held in the Company on the Record Date, as outlined in the circular published on 4 November 2022. The exercise price is equal to the undiluted NAV per share on 30 November one year prior. The aim of the programme is to enable to Company to grow through share issuance and it is subject to shareholder review at the annual general meeting ("AGM") in 2027 and at every fifth subsequent AGM thereafter.

 

 

Enquiries

 

Manulife | CQS Investment Management

Craig Cleland

 

 

+44 (0) 20 7201 5368

Cavendish Capital Markets Limited

Robert Peel (Corporate Finance)

Daniel Balabanoff / Pauline Tribe (Sales)

 

 

+44 (0) 20 7908 6000

+44 (0) 20 7720 0500

Apex Fund and Corporate Services (Guernsey) Limited

James Taylor

 

 

+44 (0) 203 5303 600

Tavistock

Jos Simson / Gareth Tredway / Ruairi Millar

 

+44 (0) 20 7920 3150

 

 

About Golden Prospect Precious Metals

Golden Prospect Precious Metals Limited is a closed-ended investment company incorporated with limited liability in Guernsey on 16 October 2006. The Company's investment objective is to provide Shareholders with capital growth from a portfolio of companies involved in the precious metals sector.

For the latest factsheet and other information, click here.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVUPGBGPUPAGWB
Date   Source Headline
2nd Jan 20262:09 pmRNSNet Asset Value(s)
31st Dec 202512:44 pmRNSNet Asset Value(s)
30th Dec 202512:48 pmRNSNet Asset Value(s)
29th Dec 202510:47 amRNSNet Asset Value(s)
24th Dec 202511:05 amRNSNet Asset Value(s)
23rd Dec 202511:34 amRNSNet Asset Value(s)
23rd Dec 20259:37 amRNSMonthly Investor Report November 2025
23rd Dec 20259:37 amRNSMonthly Investor Report November 2025
23rd Dec 20257:00 amRNSFurther re Result of Subscription Rights Exercise
23rd Dec 20257:00 amRNSFurther re Result of Subscription Rights Exercise
22nd Dec 20255:22 pmRNSNet Asset Value(s)
19th Dec 20252:59 pmRNSNet Asset Value(s)
18th Dec 202511:04 amRNSNet Asset Value(s)
17th Dec 20251:38 pmRNSNet Asset Value(s)
16th Dec 20251:34 pmRNSNet Asset Value(s)
15th Dec 20252:23 pmRNSNet Asset Value(s)
12th Dec 202512:40 pmRNSNet Asset Value(s)
11th Dec 20253:13 pmRNSNet Asset Value(s)
10th Dec 20251:36 pmRNSNet Asset Value(s)
9th Dec 20251:21 pmRNSNet Asset Value(s)
8th Dec 202511:46 amRNSNet Asset Value(s)
5th Dec 20251:31 pmRNSNet Asset Value(s)
4th Dec 20253:04 pmRNSNet Asset Value(s)
4th Dec 20257:00 amRNSReplacement - Net Asset Value(s)
3rd Dec 20254:37 pmRNSNet Asset Value(s)
3rd Dec 20258:00 amRNSShareholders Notification 2026 Subscription Rights
3rd Dec 20257:00 amRNSFurther re Result of subscription rights exercise
2nd Dec 20251:47 pmRNSNet Asset Value(s)
2nd Dec 202510:58 amRNSResult of subscription rights exercise
1st Dec 20252:06 pmRNSNet Asset Value(s)
28th Nov 202512:42 pmRNSNet Asset Value(s)
27th Nov 202512:55 pmRNSNet Asset Value(s)
27th Nov 20257:00 amRNS-RKepler Trust Intelligence: New Research
26th Nov 202512:19 pmRNSNet Asset Value(s)
26th Nov 202511:12 amRNSMonthly Investor Report - October 2025
25th Nov 202511:35 amRNSNet Asset Value(s)
24th Nov 202512:32 pmRNSNet Asset Value(s)
21st Nov 20253:14 pmRNSNet Asset Value(s)
21st Nov 20257:00 amRNS-RInvestment Company of the Year Awards 2025
20th Nov 202511:47 amRNSNet Asset Value(s)
19th Nov 202511:43 amRNSNet Asset Value(s)
18th Nov 202512:32 pmRNSNet Asset Value(s)
17th Nov 20254:18 pmRNSNet Asset Value(s)
14th Nov 20252:07 pmRNSNet Asset Value(s)
13th Nov 202512:14 pmRNSNet Asset Value(s)
12th Nov 20253:33 pmRNSNet Asset Value(s)
11th Nov 20252:54 pmRNSNet Asset Value(s)
10th Nov 202512:03 pmRNSNet Asset Value(s)
7th Nov 202512:08 pmRNSNet Asset Value(s)
6th Nov 202512:04 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.